Biomarin Pharmaceutical (BMRN) Construction in Progress (2010 - 2013)
Biomarin Pharmaceutical (BMRN) reported Construction in Progress of $77.21 million for Q4 2013, up 20.1% from $64.3 million a year earlier and up 19.2% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Construction in Progress (2010 - 2013) Analysis & Trends
Dating back to Q4 2010, Biomarin Pharmaceutical's Construction in Progress record includes 10 quarters.
- Construction in Progress has increased for three consecutive years, with a three-year compound annual growth rate of 73.7% (FY2010 to FY2013).
- By year, Construction in Progress came in at $64.3 million in FY2012 (+19.3%), $53.88 million in FY2011 (+265.8%) and $14.73 million in FY2010.
- The Q4 2013 figure ranks as the highest quarterly Construction in Progress in data going back to Q4 2010.
- Year over year, Construction in Progress has now increased in each of the last five quarters, with growth averaging 17.8% over the last five quarters.
- Per Business Quant data, the three quarters before Q4 2013 came in at $64.76 million (Q3 2013), $68.21 million (Q2 2013) and $66.67 million (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 77.21 Mn |
| Sep 30, 2013 | 64.76 Mn |
| Jun 30, 2013 | 68.21 Mn |
| Mar 31, 2013 | 66.67 Mn |
| Dec 31, 2012 | 64.30 Mn |
| Sep 30, 2012 | 54.90 Mn |
| Jun 30, 2012 | 61.64 Mn |
| Mar 31, 2012 | 55.03 Mn |
| Dec 31, 2011 | 53.88 Mn |
| Dec 31, 2010 | 14.73 Mn |
API Access
Biomarin Pharmaceutical Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();